Download presentation
Presentation is loading. Please wait.
Published bySamantha Barnett Modified over 6 years ago
1
Non-vitamin k antagonist oral anticoagulants in a European primary care physician survey
by Claudio Cimminiello, Robert Hatala, Sami Pakarinen, Hernan Polo Friz, David Fitzmaurice, and FD Richard Hobbs Br J Gen Pract Open Volume 2(3):bjgpopen18X101602 October 16, 2018 Copyright © The Authors, 2018
2
Responsibility and confidence in initiation and ongoing management of NOACs
Responsibility and confidence in initiation and ongoing management of NOACs NOAC = non-vitamin K antagonist oral anticoagulant. VKA = vitamin K antagonist. Claudio Cimminiello et al. BJGP Open 2018;2:bjgpopen18X101602 Copyright © The Authors, 2018
3
Familiarity with atrial fibrillation stroke guidelines on NOACs use and anticoagulant switching
Familiarity with atrial fibrillation stroke guidelines on NOACs use and anticoagulant switching NOAC = non-VKA oral anticoagulant. VKA = vitamin K antagonist. Claudio Cimminiello et al. BJGP Open 2018;2:bjgpopen18X101602 Copyright © The Authors, 2018
4
Perceived information needs
Perceived information needs NOAC = non-VKA oral anticoagulant. PCP = primary care physician. VKA = vitamin K antagonist. Claudio Cimminiello et al. BJGP Open 2018;2:bjgpopen18X101602 Copyright © The Authors, 2018
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.